Skip to main content
Log in

Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Acute graft-versus-host disease (GvHD) is a constant and severe complication after allogeneic stem cell transplantation regularly involving skin, liver, gut, and lungs. The cytokine interleukin-18 (IL-18) has been shown to increase in patients who develop acute GvHD after bone marrow tranplantation (BMT).

Materials and methods

Here, we measured IL-18 serum levels after peripheral blood stem cell transplantation (PBSCT) at several characteristic time points in 24 patients (median age 46 years). Patients received a median of 7.3×106/kg bodyweight CD34-positive blood stem cells from HLA-matched family donors (n=5), matched unrelated donors (n=18), and one mismatched unrelated donor. GvHD prophylaxis consisted of cyclosporin A alone or combined with methotrexate and/or mycophenolate mofetil.

Results

In 14 patients we observed no GvHD or only GvHD grade I whereas ten patients developed GvHD grade II–IV post transplant. Low, intermediate, and high levels of serum IL-18 were found in patients after allogeneic PBSCT independently of GvHD after transplantation. In contrast to GvHD arising after BMT, there was no clear correlation between absolute IL-18 serum levels and GvHD grade after PBSCT. However, the individual time course of IL-18 serum level after engraftment correlates with acute GvHD after PBSCT. In detail, an increase of serum IL-18 of at least 1.6-fold after engraftment is associated with acute GvHD II or higher with a sensitivity of three out of four. Using the 1.6 “cut-off” for IL-18 increase after engraftment, a specificity of up to 100% can be achieved.

Conclusion

The time course of IL-18 serum levels might be used for GvHD prediction after PBSCT comparable to absolute serum levels after BMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Glucksberg H, Storb R, Fefer A, et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295–304

    CAS  PubMed  Google Scholar 

  2. Poletti V, Salvucci M, Zanchini R, et al (2000) The lung as a target organ in patients with hematologic disorders. Haemotologica 85:855–864

    CAS  Google Scholar 

  3. Khurshid I, Anderson LC (2002) Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med J 78:257–262

    Article  CAS  PubMed  Google Scholar 

  4. Korngold R, Sprent J (1987) T-cell subset and graft-versus-host disease. Transplantation 44:335–339

    CAS  PubMed  Google Scholar 

  5. Krenger W, Ferrara JLM (1996) Graft-versus-host disease and the Th1/Th2 paradigm. Immunol Res 15:50–73

    CAS  PubMed  Google Scholar 

  6. Krenger W, Hill GR, Ferrara JLM (1997) Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553–558

    Article  CAS  PubMed  Google Scholar 

  7. Antin JH, Ferrara JLM (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964–2968

    CAS  PubMed  Google Scholar 

  8. Niederwieser D, Herold M, Woloszczuk W, et al (1990) Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 50:620–625

    CAS  PubMed  Google Scholar 

  9. Bonnotte B, Burdiles AM, Chehimi J, et al (1996) Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation. Eur Cytokine Netw 7:389–394

    CAS  PubMed  Google Scholar 

  10. Okamura H, Tsutsui H, Komastu T, et al (1995) Cloning of a new cytokine that induces IFN- production by T cells. Nature 378:88–91

    Article  CAS  PubMed  Google Scholar 

  11. Dao T, Ohashi K, Kayano T, et al (1996) Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 173:230–235

    Article  CAS  PubMed  Google Scholar 

  12. Okamoto I, Kohno K, Tanimoto T, et al (1999) Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. J Immunol 162:3202–3211

    CAS  PubMed  Google Scholar 

  13. Okamura H, Kashiwamura S, Tsutsui H, et al (1998a) Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10:259–264

    Article  CAS  PubMed  Google Scholar 

  14. Okamura H, Tsutsui H, Kashiwamura S, et al (1998b) Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70:281–312

    CAS  PubMed  Google Scholar 

  15. Fantuzzi G, Puren AJ, Harding MW, et al (1998) Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 91:2118–2125

    CAS  PubMed  Google Scholar 

  16. Gu Y, Kuida K, Tsutsui H, et al (1997) Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275:206–209

    Article  CAS  PubMed  Google Scholar 

  17. Aizawa Y, Akita K, Taniai M, et al (1999) Cloning and expression of interleukin-18 binding protein. FEBS Lett 26:338–342

    Article  Google Scholar 

  18. Zecchina G, Novick D, Rubinstein M, et al (2001) Interleukin-18 binding protein in acute graft-versus-host disease and engraftment following allogeneic peripheral blood stem cell transplants. J Hematother Stem Cell Res 10:769–776

    Article  CAS  PubMed  Google Scholar 

  19. Fujimori Y, Takatsuka H, Takemoto Y, et al (2000) Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 109:652–657

    Article  CAS  PubMed  Google Scholar 

  20. Reddy P, Ferrara JL (2003) Role of interleukin-18 in acute graft-vs-host disease. J Lab Clin Med 141:365–371

    Article  CAS  PubMed  Google Scholar 

  21. Reddy P, Teshima T, Kukuruga M, et al (2001) Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J Exp Med 194:1433–1440

    Article  CAS  PubMed  Google Scholar 

  22. Itoi H, Fujimori Y, Tsutsui H, et al (2001) Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease. Blood 98:235–237

    Article  CAS  PubMed  Google Scholar 

  23. Shankar G, Bryson JS, Jennings CD, et al (1998) Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation. Am J Respir Cell Mol Biol 18:235–242

    CAS  PubMed  Google Scholar 

  24. Cooke KR, Krenger W, Hill G, et al (1998) Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 92:2571–2580

    CAS  PubMed  Google Scholar 

  25. Bensinger WI, Martin PJ, Storer B, et al (2001) Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. NEJM 344:175–181

    Article  CAS  PubMed  Google Scholar 

  26. Flowers M, Parker PM, Johnston LJ, et al (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100:415–419

    Article  CAS  PubMed  Google Scholar 

  27. Slavin S, Nagler A, Naparstek E, et al (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 3:756–763

    Google Scholar 

  28. Sevilla J, Gonzalez-Vicent M, Mader L, et al (2002) Early onset of acute immune-mediated lung injury in a child undergoing allogeneic peripheral blood transplantation. Am J Hematol 69:56–58

    Article  PubMed  Google Scholar 

  29. Arndt PG, Fantuzzi G, Abraham E (2000) Expression of interleukin-18 in the lung after endotoxinemia or hemorrhage-induced acute lung injury. Am J Respir Cell Mol Biol 22:708–713

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Anja Markusch for her contributions to patient characteristics and Ms. Herrmann and Ms. Franke who determined cellular subpopulations of grafts and CD34 content of transplants

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sebastian Scholl.

Additional information

S. Scholl and H. G. Sayer contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scholl, S., Sayer, H.G., Mügge, LO. et al. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation. J Cancer Res Clin Oncol 130, 704–710 (2004). https://doi.org/10.1007/s00432-004-0603-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-004-0603-6

Keywords

Navigation